55 related articles for article (PubMed ID: 15668475)
1. Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays.
Rinaldi S; Kaaks R; Zeleniuch-Jacquotte A; Arslan AA; Shore RE; Koenig KL; Dossus L; Riboli E; Stattin P; Lukanova A; Toniolo P
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):48-52. PubMed ID: 15668475
[TBL] [Abstract][Full Text] [Related]
2. Eighteen insulin-like growth factor pathway genes, circulating levels of IGF-I and its binding protein, and risk of prostate and breast cancer.
Gu F; Schumacher FR; Canzian F; Allen NE; Albanes D; Berg CD; Berndt SI; Boeing H; Bueno-de-Mesquita HB; Buring JE; Chabbert-Buffet N; Chanock SJ; Clavel-Chapelon F; Dumeaux V; Gaziano JM; Giovannucci EL; Haiman CA; Hankinson SE; Hayes RB; Henderson BE; Hunter DJ; Hoover RN; Johansson M; Key TJ; Khaw KT; Kolonel LN; Lagiou P; Lee IM; LeMarchand L; Lund E; Ma J; Onland-Moret NC; Overvad K; Rodriguez L; Sacerdote C; Sánchez MJ; Stampfer MJ; Stattin P; Stram DO; Thomas G; Thun MJ; Tjønneland A; Trichopoulos D; Tumino R; Virtamo J; Weinstein SJ; Willett WC; Yeager M; Zhang SM; Kaaks R; Riboli E; Ziegler RG; Kraft P
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2877-87. PubMed ID: 20810604
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, and breast cancer risk: observational and Mendelian randomization analyses with ∼430 000 women.
Murphy N; Knuppel A; Papadimitriou N; Martin RM; Tsilidis KK; Smith-Byrne K; Fensom G; Perez-Cornago A; Travis RC; Key TJ; Gunter MJ
Ann Oncol; 2020 May; 31(5):641-649. PubMed ID: 32169310
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the insulin-like growth factor-1 signaling pathway in localized Ewing sarcoma: a report from the Children's Oncology Group.
Borinstein SC; Barkauskas DA; Krailo M; Scher D; Scher L; Schlottmann S; Kallakury B; Dickman PS; Pawel BR; West DC; Womer RB; Toretsky JA
Cancer; 2011 Nov; 117(21):4966-76. PubMed ID: 21480204
[TBL] [Abstract][Full Text] [Related]
5. Plasma IGFBP-3 and IGFBP-5 levels are decreased during acute manic episodes in bipolar disorder patients.
Fernández-Pereira C; Penedo MA; Alonso-Núñez A; Rivera-Baltanás T; Viéitez I; Prieto-González JM; Vilariño-Vilariño MI; Olivares JM; Ortolano S; Agís-Balboa RC
Front Pharmacol; 2024; 15():1384198. PubMed ID: 38720780
[No Abstract] [Full Text] [Related]
6. Biomarkers of Insulin and the Insulin-Like Growth Factor Axis in Relation to Breast Cancer Risk in Chinese Women.
Zhu Y; Wang T; Wu J; Huang O; Zhu L; He J; Li Y; Chen W; Chen X; Shen K
Onco Targets Ther; 2020; 13():8027-8036. PubMed ID: 32848423
[TBL] [Abstract][Full Text] [Related]
7. Dose-dependent effect of aerobic exercise on inflammatory biomarkers in a randomized controlled trial of women at high risk of breast cancer.
Haley JS; Hibler EA; Zhou S; Schmitz KH; Sturgeon KM
Cancer; 2020 Jan; 126(2):329-336. PubMed ID: 31568587
[TBL] [Abstract][Full Text] [Related]
8. Insulin-Like Growth Factor I Receptor (IGF-IR) Ligands and BMI in Squamous Intra-Epithelial Lesion (SIL) of Cervix.
Sablania P; Batra S; Saxena A
J Clin Diagn Res; 2016 Feb; 10(2):BC11-5. PubMed ID: 27042445
[TBL] [Abstract][Full Text] [Related]
9. Association between endogenous sex steroid hormones and insulin-like growth factor proteins in US men.
Papatheodorou SI; Rohrmann S; Lopez DS; Bradwin G; Joshu CE; Kanarek N; Nelson WG; Rifai N; Platz EA; Tsilidis KK
Cancer Causes Control; 2014 Mar; 25(3):353-63. PubMed ID: 24395140
[TBL] [Abstract][Full Text] [Related]
10. The relationship between dioxin-like polychlorobiphenyls and IGF-I serum levels in healthy adults: evidence from a cross-sectional study.
Luzardo OP; Henríquez-Hernández LA; Valerón PF; Lara PC; Almeida-González M; Losada A; Zumbado M; Serra-Majem L; Alvarez-León EE; Boada LD
PLoS One; 2012; 7(5):e38213. PubMed ID: 22666488
[TBL] [Abstract][Full Text] [Related]
11. Genetic variants, prediagnostic circulating levels of insulin-like growth factors, insulin, and glucose and the risk of colorectal cancer: the Multiethnic Cohort study.
Ollberding NJ; Cheng I; Wilkens LR; Henderson BE; Pollak MN; Kolonel LN; Le Marchand L
Cancer Epidemiol Biomarkers Prev; 2012 May; 21(5):810-20. PubMed ID: 22354904
[TBL] [Abstract][Full Text] [Related]
12. Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition.
Rohrmann S; Grote VA; Becker S; Rinaldi S; Tjønneland A; Roswall N; Grønbæk H; Overvad K; Boutron-Ruault MC; Clavel-Chapelon F; Racine A; Teucher B; Boeing H; Drogan D; Dilis V; Lagiou P; Trichopoulou A; Palli D; Tagliabue G; Tumino R; Vineis P; Mattiello A; Rodríguez L; Duell EJ; Molina-Montes E; Dorronsoro M; Huerta JM; Ardanaz E; Jeurnink S; Peeters PH; Lindkvist B; Johansen D; Sund M; Ye W; Khaw KT; Wareham NJ; Allen NE; Crowe FL; Fedirko V; Jenab M; Michaud DS; Norat T; Riboli E; Bueno-de-Mesquita HB; Kaaks R
Br J Cancer; 2012 Feb; 106(5):1004-10. PubMed ID: 22315049
[TBL] [Abstract][Full Text] [Related]
13. Circulating insulin-like growth factor (IGF)-I and IGF binding protein (IGFBP)-3 levels and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial (PLCO) cohort.
Schairer C; McCarty CA; Isaacs C; Sue LY; Pollak MN; Berg CD; Ziegler RG
Horm Cancer; 2010 Apr; 1(2):100-11. PubMed ID: 21761353
[TBL] [Abstract][Full Text] [Related]
14. The proliferating role of insulin and insulin-like growth factors in cancer.
Gallagher EJ; LeRoith D
Trends Endocrinol Metab; 2010 Oct; 21(10):610-8. PubMed ID: 20663687
[TBL] [Abstract][Full Text] [Related]
15. Plasma insulin-like growth factor 1 is positively associated with low-grade prostate cancer in the Health Professionals Follow-up Study 1993-2004.
Nimptsch K; Platz EA; Pollak MN; Kenfield SA; Stampfer MJ; Willett WC; Giovannucci E
Int J Cancer; 2011 Feb; 128(3):660-7. PubMed ID: 20473871
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies.
; Key TJ; Appleby PN; Reeves GK; Roddam AW
Lancet Oncol; 2010 Jun; 11(6):530-42. PubMed ID: 20472501
[TBL] [Abstract][Full Text] [Related]
17. Unraveling insulin-like growth factor binding protein-3 actions in human disease.
Jogie-Brahim S; Feldman D; Oh Y
Endocr Rev; 2009 Aug; 30(5):417-37. PubMed ID: 19477944
[TBL] [Abstract][Full Text] [Related]
18. Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis.
Rowlands MA; Gunnell D; Harris R; Vatten LJ; Holly JM; Martin RM
Int J Cancer; 2009 May; 124(10):2416-29. PubMed ID: 19142965
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies.
Roddam AW; Allen NE; Appleby P; Key TJ; Ferrucci L; Carter HB; Metter EJ; Chen C; Weiss NS; Fitzpatrick A; Hsing AW; Lacey JV; Helzlsouer K; Rinaldi S; Riboli E; Kaaks R; Janssen JA; Wildhagen MF; Schröder FH; Platz EA; Pollak M; Giovannucci E; Schaefer C; Quesenberry CP; Vogelman JH; Severi G; English DR; Giles GG; Stattin P; Hallmans G; Johansson M; Chan JM; Gann P; Oliver SE; Holly JM; Donovan J; Meyer F; Bairati I; Galan P
Ann Intern Med; 2008 Oct; 149(7):461-71, W83-8. PubMed ID: 18838726
[TBL] [Abstract][Full Text] [Related]
20. Intact and total insulin-like growth factor-binding protein-3 (IGFBP-3) levels in relation to breast cancer risk factors: a cross-sectional study.
Diorio C; Brisson J; Bérubé S; Pollak M
Breast Cancer Res; 2008; 10(3):R42. PubMed ID: 18471292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
